CannabisNewsBreaks

WednesdaySep 26, 2018 10:26 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Joint Venture Agreement with Asterion Cannabis Inc.

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced its entry into an agreement to form a joint venture focused on the development of a range of medicinal cannabinoid products, including sublingual tablets, transdermal patches and other jointly evaluated products aimed at treating various ailments such as chronic pain, inflammation, epilepsy and anxiety disorders. “This agreement between PreveCeutical and Asterion further supports our mission to improve global health and healthcare by utilizing innovative science and cutting-edge technology to enhance natural products,” Stephen Van Deventer, chairman, CEO and president of PreveCeutical, stated in the news release.…

Continue Reading

WednesdaySep 26, 2018 9:40 am

CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Company Receives First Purchase Order

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has secured its first purchase order for THC distillate in the amount of $840,000. The purchase order received from a high volume, top California cannabis brand specified $840,000 as the minimum annual amount. Monthly volumes and the related payments may increase based on reliable delivery and performance. “To secure a large purchase order from a top California brand is a testament to the stature of the Refined Resin team and bodes well for…

Continue Reading

TuesdaySep 25, 2018 4:30 pm

CannabisNewsBreaks – The Flowr Corp. (TSX.V: FLWR) Featured in Benzinga Article ahead of Public Listing

The Flowr Corp. (TSX.V: FLWR), a vertically integrated Canadian cannabis company, was the subject of a recent article published by Benzinga, titled ‘Canada's Flowr Corp. Prepares To Go Public, Bets On Premium Cannabis, Eyes Global Expansion’. As noted in the article, Flowr went public via a reverse takeover of The Needle Capital Corp., allowing it to avoid the need for an IPO. The company intends to list on a U.S. exchange at a future date. “Many of the large producers need to irradiate all of their product to pass Health Canada inspection and that hurts the flavor and smell of…

Continue Reading

TuesdaySep 25, 2018 2:58 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Solves Unique Challenges Faced by the Cannabis Industry

BLOCKStrain Technology (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, offers the cannabis market a single-source accountability system. A recent article discussing the company’s innovative platform reads: “While supply chain transparency and verification are ongoing issues for various industries, in an emerging industry like the cannabis market, in which regulations are still being established and the proverbial kinks are still being worked out, the need for a reliable means of seed-to-sale tracking is even more acute. … Until recently, cannabis products were largely available only on the black market. As cannabis availability and legalization now continue to expand…

Continue Reading

TuesdaySep 25, 2018 10:19 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Provides Update on Spin-off Transaction; Subsidiary Intends to Complete Offering of Subscription Receipts

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning provided an update on the spin-off transaction regarding its wholly-owned subsidiary, TGOD Acquisition Corporation ("SpinCo"). The distribution record date is expected to be on or about November 16, 2018, subject to execution of an arrangement agreement between the company and SpinCo and receipt of requisite corporate, regulatory and court approvals. Per the arrangement agreement, TGOD shareholders of record as of the distribution date will receive 0.15 of one SpinCo unit warrant for each TGOD share held. Each unit warrant will entitle the holder to…

Continue Reading

TuesdaySep 25, 2018 9:22 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Gains Inclusion in the Horizons Marijuana Life Sciences (TSX: HMMJ) ETF

British Columbia-based fully-integrated cannabis company Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has been added to the Horizons Marijuana Life Sciences (TSX: HMMJ) exchange-traded fund (“ETF”). As the world’s first and largest ETF, HMMJ delivers exposure directly to North American publicly listed life sciences companies that engage in the marijuana industry. "Choom's addition to the Horizons Marijuana Life Sciences ETF is recognition of our efforts to building a dominant branded cannabis company. The Choom brand was created exclusively to service the retail recreational market, ensuring curious customers and cannabis connoisseurs alike can 'cultivate good times',"…

Continue Reading

MondaySep 24, 2018 10:38 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adds Tim Seymour to Advisory Board

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its appointment of American businessman, investor and television personality Tim Seymour to its advisory board. Per the update, Seymour is best known for his role with CNBC as a recognized trader and market specialist on ‘Fast Money’. He brings more than two decades of experience as a portfolio manager and capital markets professional to the TGOD team. “Tim is one of the most recognizable finance professionals in America and we are thrilled to have him join our team,” Brian Athaide, CEO of…

Continue Reading

MondaySep 24, 2018 10:25 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Claims Spot on CSE 25 Index

British Columbia-based fully-integrated cannabis company Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has been added to the Canadian Securities Exchange’s CSE 25 Index, effective September 21, 2018, at market close. Per the update, the index includes the top 25 securities in the CSE’s composite index ranked by market capitalization. “We are proud of our inclusion in the CSE 25 Index and being recognized as one of the top performers on the CSE,” Chris Bogart, president and CEO of Choom, stated in the news release. “Choom is committed to providing a growth opportunity for shareholders as…

Continue Reading

FridaySep 21, 2018 2:14 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH™, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH™ was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://cnw.fm/0l9eM). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,…

Continue Reading

FridaySep 21, 2018 2:07 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategically Employs R&D Strategy to Achieve Increased Productivity

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to give its investors more bang for their buck when it comes to research and development (“R&D”), as it has been proven that smaller companies achieve higher R&D productivity. A recent article discussing the company reads: “PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has taken this advice to heart. The health sciences company has three distinct research programs underway. Top of the line is a non-opioid pain treatment based on cannabinoids to be administered through a proprietary nose-to-brain, soluble gel (Sol-gel) drug delivery system. The research…

Continue Reading